CB1 Capital Management predicts Cannabis could disrupt the healthcare industry in a big way. The firm's Founding Partner and Chief Investment Officer Todd Harrison explains why he thinks medical marijuana will migrate from state dispensaries, to become medicine prescribed by doctors through insurance in the next decade.
Harrison says the only way the U.S. government would get their hands on the money in this market opportunity is through the FDA. "That's where we think it goes, follow the money," says Harrison.
"This is not so much a trade about commerce, as it is a trade about healthcare," said Harrison. "We think that this is going to migrate towards medicine." One of CB1 Capital Management's holdings GW Pharmaceuticals is up 30 percent over the past three months. Harrison expects this company to publish research showing the efficacy of cannabis treatment this summer.
Tech stocks are rallying on strong earnings and massive AI investment. Investors are watching Nvidia & hyperscaler spending for clues on how long it will last.
Sean Klitzner, showrunner and co-creator of Beast Games, previews the Feb. 25 finale packed with bigger stunts, wild twists, and the highest stakes yet.
Bob Sallmann, CFO of McGraw Hill, breaks down the quarter’s standout performance, digital expansion, and how AI tools are driving education innovation.
Daniel Desrochers, International Trade Reporter at POLITICO, joins us to break down the ruling, the billions at stake, and what it means for consumers.
